About this trial
Functional Outcomes and Control Using Synchron BCI - Australia (FOCUS-AUS)
Eligibility criteria
Qualifiers
Able to provide informed consent to participate in the study.
Bilateral upper-limb paresis or Amyotrophic lateral sclerosis (ALS) with bilateral upper limb paresis
The underlying condition causing motor impairment must be refractory to treatment and have been present for a minimum of twelve months.
Aged 21 years or older
Disqualifiers
Unrealistic expectations regarding the potential benefits of the device.
Active infection or unexplained fever in the 48 hours prior to informed consent
Major psychiatric disorder that may adversely impact the participant's safety or study compliance, including severe depression, psychotic features, personality disorder, severe emotional lability, or substance abuse.
Dementia or cognitive dysfunction that would impact the participant's ability to participate in study activities.
Trial design
Treatments tested in this trial
- Stentrode